Clinical Trial Update: The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial update for DESIFOR assessing statin intolerance in rosuvastatin users, focusing on cardiovascular risk factors/diseases and adverse effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Minneapolis Heart Institute Foundation | Conditions: Cardiovascular Risk Factor, Cardiovascular Diseases | Phase 4 | Status: UNKNOWN